rhofadehcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Allow: / Host: https://www.rhofadehcp.com Sitemap: | ||
Meta Tags
| Title | RHOFADE® (oxymetazoline HCl) cream, |
| Description | More than Face RHOFADE® | Beyond the surface of persistent facial |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 173.203.188.208 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
rhofadehcp.com Valuation
|
US$3,788,035
Last updated: 2023-05-13 21:41:19
rhofadehcp.com has Semrush global rank of 2,794,141. rhofadehcp.com has an estimated worth of US$ 3,788,035, based on its estimated Ads revenue. rhofadehcp.com receives approximately 437,081 unique visitors each day. Its web server is located in United States, with IP address 173.203.188.208. According to SiteAdvisor, rhofadehcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,788,035 |
| Daily Ads Revenue | US$3,497 |
| Monthly Ads Revenue | US$104,900 |
| Yearly Ads Revenue | US$1,258,794 |
| Daily Unique Visitors | 29,139 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| rhofadehcp.com. | A | 599 | IP: 173.203.188.208 |
| rhofadehcp.com. | NS | 3600 | NS Record: ns44.domaincontrol.com. |
| rhofadehcp.com. | NS | 3600 | NS Record: ns43.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-13 21:41:19
| The challenge of PERSISTENT FACIAL ERYTHEMA (PFE) is More than Face value There’s what patients see and what you should target Actual PFE patient Explore the benefits The challenge of PERSISTENT FACIAL ERYTHEMA (PFE) is More than Face value There’s what patients see and what you should target Actual PFE patient Explore the benefits Chronic vascular dysregulation CAUSES PFE 1,2 PFE in rosacea—which does not respond to treatments for papules and pustules—is primarily caused by chronic vascular dysregulation . Vasodilation increases cutaneous blood flow at affected sites, leading to facial erythema that may become permanent over time if left untreated. 3 Targeted Mechanism of action 4 RHOFADE is the first and only alpha 1A -adrenoceptor agonist approved to treat PFE in rosacea, causing constriction of smooth muscle in blood vessel walls to help prevent progression and reduce PFE. RHOFADE provides an opportunity to address chronic vascular dysregulation and target PFE at the source. 2,4 |
HTTP Headers
HTTP/1.1 200 OK Date: Wed, 22 Dec 2021 04:33:51 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
rhofadehcp.com Whois Information
Domain Name: RHOFADEHCP.COM Registry Domain ID: 2044190204_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-19T13:30:21Z Creation Date: 2016-07-18T21:20:53Z Registry Expiry Date: 2022-07-18T21:20:53Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS43.DOMAINCONTROL.COM Name Server: NS44.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T07:27:19Z <<< |